Cargando…

The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study

INTRODUCTION: The frozen elephant trunk technique (FET) has become routine for aortic arch and descending aortic repair. New hybrid prosthesis models are constantly being developed to increase effectiveness and durability of aortic repair. Recently, concerns were raised regarding increased post-oper...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Sayed Ahmad, Ali, Silaschi, Miriam, Borger, Michael, Seidiramool, Vahid, Hamiko, Marwan, Leontyev, Sergey, Zierer, Andreas, Doss, Mirko, Etz, Christian D., Benedikt, Peter, Bramlage, Peter, Bakhtiary, Farhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988725/
https://www.ncbi.nlm.nih.gov/pubmed/36633731
http://dx.doi.org/10.1007/s12325-022-02418-5
_version_ 1784901628679159808
author El-Sayed Ahmad, Ali
Silaschi, Miriam
Borger, Michael
Seidiramool, Vahid
Hamiko, Marwan
Leontyev, Sergey
Zierer, Andreas
Doss, Mirko
Etz, Christian D.
Benedikt, Peter
Bramlage, Peter
Bakhtiary, Farhad
author_facet El-Sayed Ahmad, Ali
Silaschi, Miriam
Borger, Michael
Seidiramool, Vahid
Hamiko, Marwan
Leontyev, Sergey
Zierer, Andreas
Doss, Mirko
Etz, Christian D.
Benedikt, Peter
Bramlage, Peter
Bakhtiary, Farhad
author_sort El-Sayed Ahmad, Ali
collection PubMed
description INTRODUCTION: The frozen elephant trunk technique (FET) has become routine for aortic arch and descending aortic repair. New hybrid prosthesis models are constantly being developed to increase effectiveness and durability of aortic repair. Recently, concerns were raised regarding increased post-operative bleeding using a new-generation hybrid prosthesis (E-vita(®) OPEN NEO, CryoLife Inc. JOTEC GmbH, Hechingen, Germany). We report the outcomes of a multi-centre experience of using the E-vita OPEN NEO. METHODS: All patients undergoing aortic surgery at five European centres using the E-vita OPEN NEO from 2020 to 2022 were included (n = 22). The primary endpoint was the amount of chest drain fluid after 24 h and re-thoracotomy rate for bleeding. RESULTS: Median patient age was 62.5 ± 12.6 years, 50.0% (11/22 patients) were female and 27.3% (6/22) of procedures were re-operative cardiac surgeries. Aortic dissection was present in 54.5% (12/22). The median cardiopulmonary bypass time was 148 min and ischaemia time was 84 min. Mortality at 30 days was 4.5% (1/22) and the stroke rate was 18.2% (4/22). The rate of re-thoracotomy for bleeding was 4.5% (1/22) with a median amount of chest drain fluid within 24 h of 569 (IQR 338–910) ml. There were no device-associated adverse events. CONCLUSIONS: Use of this new-generation hybrid prosthesis for FET was safe and effective. Patient follow-up was largely uneventful given the extent of the procedures performed. In particular, bleeding events were uncommon in this cohort of patients comprising many aortic dissections and re-operative procedures. No increase in oozing was observed. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9988725
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-99887252023-03-08 The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study El-Sayed Ahmad, Ali Silaschi, Miriam Borger, Michael Seidiramool, Vahid Hamiko, Marwan Leontyev, Sergey Zierer, Andreas Doss, Mirko Etz, Christian D. Benedikt, Peter Bramlage, Peter Bakhtiary, Farhad Adv Ther Original Research INTRODUCTION: The frozen elephant trunk technique (FET) has become routine for aortic arch and descending aortic repair. New hybrid prosthesis models are constantly being developed to increase effectiveness and durability of aortic repair. Recently, concerns were raised regarding increased post-operative bleeding using a new-generation hybrid prosthesis (E-vita(®) OPEN NEO, CryoLife Inc. JOTEC GmbH, Hechingen, Germany). We report the outcomes of a multi-centre experience of using the E-vita OPEN NEO. METHODS: All patients undergoing aortic surgery at five European centres using the E-vita OPEN NEO from 2020 to 2022 were included (n = 22). The primary endpoint was the amount of chest drain fluid after 24 h and re-thoracotomy rate for bleeding. RESULTS: Median patient age was 62.5 ± 12.6 years, 50.0% (11/22 patients) were female and 27.3% (6/22) of procedures were re-operative cardiac surgeries. Aortic dissection was present in 54.5% (12/22). The median cardiopulmonary bypass time was 148 min and ischaemia time was 84 min. Mortality at 30 days was 4.5% (1/22) and the stroke rate was 18.2% (4/22). The rate of re-thoracotomy for bleeding was 4.5% (1/22) with a median amount of chest drain fluid within 24 h of 569 (IQR 338–910) ml. There were no device-associated adverse events. CONCLUSIONS: Use of this new-generation hybrid prosthesis for FET was safe and effective. Patient follow-up was largely uneventful given the extent of the procedures performed. In particular, bleeding events were uncommon in this cohort of patients comprising many aortic dissections and re-operative procedures. No increase in oozing was observed. GRAPHICAL ABSTRACT: [Image: see text] Springer Healthcare 2023-01-12 2023 /pmc/articles/PMC9988725/ /pubmed/36633731 http://dx.doi.org/10.1007/s12325-022-02418-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
El-Sayed Ahmad, Ali
Silaschi, Miriam
Borger, Michael
Seidiramool, Vahid
Hamiko, Marwan
Leontyev, Sergey
Zierer, Andreas
Doss, Mirko
Etz, Christian D.
Benedikt, Peter
Bramlage, Peter
Bakhtiary, Farhad
The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study
title The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study
title_full The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study
title_fullStr The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study
title_full_unstemmed The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study
title_short The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study
title_sort frozen elephant technique using a novel hybrid prosthesis for extensive aortic arch disease: a multicentre study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988725/
https://www.ncbi.nlm.nih.gov/pubmed/36633731
http://dx.doi.org/10.1007/s12325-022-02418-5
work_keys_str_mv AT elsayedahmadali thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT silaschimiriam thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT borgermichael thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT seidiramoolvahid thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT hamikomarwan thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT leontyevsergey thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT ziererandreas thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT dossmirko thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT etzchristiand thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT benediktpeter thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT bramlagepeter thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT bakhtiaryfarhad thefrozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT elsayedahmadali frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT silaschimiriam frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT borgermichael frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT seidiramoolvahid frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT hamikomarwan frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT leontyevsergey frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT ziererandreas frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT dossmirko frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT etzchristiand frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT benediktpeter frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT bramlagepeter frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy
AT bakhtiaryfarhad frozenelephanttechniqueusinganovelhybridprosthesisforextensiveaorticarchdiseaseamulticentrestudy